Figure 10From: Role of PPAR-δ in the development of zymosan-induced multiple organ failure: an experiment mice studyMoreover, MPO activity in lung (A) and gut (B) samples of zymosan-treated-mice was significantly increased in comparision to sham mice (A and B, respectively). Treatment with GW0742 significantly reduced the increase of MPO activity in lung (A) and gut (B). Data are mean ± standard deviation from n = 10 mice for each group. *P < 0.01 vs sham, °P < 0.01 vs zymosan + vehicle.Back to article page